A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
Recruiting · NCT05714072 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis | Myelofibrosis Due to and Following Polycythemia Vera | Recruiting | Phase 1 | 2026-09-03 | NCT05714072 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
| Incyte Corporation | 153 |
| Memorial Sloan Kettering Cancer Center | 753 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | United States | 189 |
| Memorial Sloan Kettering Bergen | Montvale | United States | 193 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Monmouth | Middletown | United States | 206 |
| Memorial Sloan Kettering Nassau (Limited Protocol Activities) | Uniondale | United States | 120 |
| Memorial Sloan Kettering Suffolk - Commack | Commack | United States | 6 |
| Memorial Sloan Kettering Westchester | East White Plains | United States | 24 |